Iatrogenic postoperative spondylodiscitis attributed to Burkholderia cepacia infection in an immunocompetent patient

CONCLUSION: Rarely, B. cepacia may be the offending organism resulting in a postoperative lumbar PS.PMID:33948309 | PMC:PMC8088530 | DOI:10.25259/SNI_518_2020
Source: Surgical Neurology International - Category: Neurosurgery Authors: Source Type: research

Related Links:

In this study, we investigated the molecular profiles of different bacterial isolates retrieved from various types of VA grafts. We collected clinical isolates from hemodialysis patients with VAIs in our institution for the period between 2013 and 2018. We identified the bacterial isolates using standard biochemical procedures; we used a polymerase chain reaction for coagulase‐nega tive staphylococci (CoNS) andBurkholderia cepacia complex (BCC) species identification. The antibiotic resistance and molecular profile were analyzed using the disk diffusion method and multilocus sequence typing, respectively. We studied 150 ...
Source: MicrobiologyOpen - Category: Microbiology Authors: Tags: Original Article Source Type: research
Publication date: November 2020Source: Plant Physiology and Biochemistry, Volume 156Author(s): Morena M. Tinte, Paul A. Steenkamp, Lizelle A. Piater, Ian A. Dubery
Source: Plant Physiology and Biochemistry - Category: Biochemistry Source Type: research
This study contributes to understanding of shared and species-specific evolutionary patterns of B. cenocepacia and B. multivorans evolving in the same CF lung environment.
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
We describe a case of an otherwise healthy, community-dwelling man who presented with subacute cavitary lung disease, the causative organism of which turned out to be Burkholderia cepacia complex.  Our report is accompanied by a review of the literature, which identified an additional eleven cases in the same category.  We analyze all of the available cases for the emergence of any identifiable patterns or peculiarities. PMID: 32959626 [PubMed - in process]
Source: Monaldi Archives for Chest Disease - Category: Respiratory Medicine Tags: Monaldi Arch Chest Dis Source Type: research
Future Microbiology,Volume 15, Issue 12, Page 1091-1093, August 2020.
Source: Future Microbiology - Category: Microbiology Authors: Source Type: research
Bacterial whole-genome sequencing (WGS) provides clinical and public health laboratories an unprecedented level of information on species identification, antimicrobial resistance, and epidemiological typing. However, multiple barriers to widespread adoption still exist. Here, we describe bacterial WGS using the Illumina iSeq 100 instrument to overcome some of these barriers. Using an in-house, high quality single nucleotide polymorphism (hqSNP) analysis pipeline and the BIOM ÉRIEUX EPISEQ CS whole-genome Multilocus Sequence Typing (wgMLST) program, we validated the sequencing of Acinetobacter baumannii, Burkholderia...
Source: Journal of Molecular Diagnostics - Category: Pathology Authors: Tags: Regular Article Source Type: research
In conclusion, the statistical approach was significantly increased the PHA production using waste glycerol as the sole carbon source.
Source: Biotechnology Progress - Category: Biotechnology Authors: Tags: RESEARCH ARTICLE Source Type: research
Centurion Labs is voluntarily recalling, as a precautionary measure, 1 lot of Ninjacof (Lot# 200N1601) and 1 lot of Ninjacof A (Lot# 201NA1601) manufactured by Vilvet (Dania Beach, FL) and distributed by Centurion Labs to the retail level due to potential contamination with Burkholderia cepacia. Centurion was notified by the FDA regarding the potential contamination as they discovered this product may have been manufactured in a Pharmatech, FDA registered facility, in Davie, FL. that was found to have a product that contained B. cepacia.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news
Stenotrophomonas maltophilia,Burkholderia cepacia complex,Elizabethkingia spp.,Chryseobacterium spp.,Achromobacter spp., andAlcaligenes spp. are less ‐common non–lactose‐fermenting bacteria that have emerged as important opportunistic pathogens. Patients at the highest risk for these infections include the immunocompromised, those with cystic fibrosis, and the critically ill. These opportunistic pathogens are frequently drug resistant throu gh the expression of β‐lactamases, multidrug efflux pumps, aminoglycoside‐modifying enzymes, and target site alterations discussed in detail throughout this review. A...
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Tags: Review Of Therapeutics Source Type: research
ConclusionThe creation of oncomicrobiotics may allow many patients receiving anti-CTLA-4 and PD-1 immunotherapy to experience prolonged survival and a better quality of life.
Source: Gut Pathogens - Category: Microbiology Source Type: research
More News: Antibiotic Therapy | Brain | Burkholderia | Burkholderia Cepacia | Neurology | Neurosurgery